No photo of Sagun Parakh

Sagun Parakh

Dr

20192024
If you made any changes in Pure these will be visible here soon.

Projects 2019 2024

Filter
Active
Active

A Phase 1a/1b, Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK112 in Subjects with Advanced Solid Tumors

Parakh, S.

15/11/19 → 14/11/24

Project: Research

Phase 1/1b Study Investigating Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Anti-TIGIT Monoclonal Antibody BGB-A1217 in combination with Anti-PD-1 Monocolonal Antibody Tislelizumab (BGB-A317) in Pateints with Unresectable Locally Advanced or Metastatic Solid Tumors

Parakh, S.

8/10/19 → 7/10/24

Project: Research

A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 Monotherapy in Subjects with Advanced Solid Tumors

Parakh, S.

24/09/19 → 23/09/24

Project: Research

Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma

Parakh, S.

20/05/19 → 19/05/24

Project: Research

A phase IB open-label, dose-escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with androgen deprivation therapy and other agents in subjects with castrate resistant prostate cancer (CRPC)

Parakh, S.

4/04/19 → 3/04/24

Project: Research

A Randomised Phase II Trial of Osimertinib with or without Stereotactic Radiosurgery for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Parakh, S.

20/03/19 → 19/03/24

Project: Research

A Phase 1 study of ES414 in Patients with Metastatic Castration Resistant Prostate Cancer

Parakh, S.

1/01/19 → 31/12/23

Project: Research